<DOC>
	<DOCNO>NCT02029599</DOCNO>
	<brief_summary>The aim study evaluate efficacy safety Fang yi qing Feng shi granule subject Rheumatoid Arthritis .</brief_summary>
	<brief_title>The Efficacy Safety Fang yi Qing Feng Shi Granules Subjects With Rheumatoid Arthritis</brief_title>
	<detailed_description>Fang yi qing feng shi granule chinese patent medicine , contain 8 kind chinese medicine . Fang yi qing feng shi granule approve China Food Drug Administration ( CFDA ) 2005 , produce mean modern technology Maoxiang Group Jilin Pharmaceutical Co. , Ltd.The study multi-center , double -blind , placebo -controlled , randomize Chinese subject Rheumatoid Arthritis ass treatment effect safety subject treat Fang yi qing feng shi granule versus subject treat placebo .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>1 . Subjects diagnosis Rheumatoid Arthritis active state . 2 . Subjects Traditional Chinese Medicine ( TCM ) diagnosis ofArthralgic Syndrome sign dampness obstruct connect vessel。 3 . Subjects must stop medicine least three month，which Diseases modify antirheumatic drug ( include glucocorticoid ) . 4 . Male female subject , age 18 65 year old . 5 . Joint function grade ray classification Ⅰ～Ⅲ . 6 . Subjects agree participate study sign inform consent form . 1 . Subjects systemic lupus erythematosus , sicca syndrome , severe osteoarthropathy exclude . 2 . Subjects severe rheumatic arthritis loss ability 3 . Allergic test drug ( basic treatment drug combination ) , Allergic constitution ( Allergic two drug ) . 4 . Female subject pregnant breastfeeding consider become pregnant . 5 . Subjects sever diseases Cardiovascular , brain , lung , liver , kidney hematopoietic system . 6 . The Liver function ( ALT , AST ) kidney function（BUN , Cr）is high normal . 7 . The Blood Routine ( leukocyte count , platelet count ) low normal . 8 . Subject consider investigator , reason , unsuitable candidate study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>